https://druganddeviceworld.com/2026/04/09/patients-open-to-non-glp-1-drugs-after-education-survey-finds/ 2026-04-09T16:39:52Z Drug and Device World en Patients open to non-GLP-1 drugs after education, survey finds 2026-04-09T16:39:50Z Blog https://druganddeviceworld.com/2026/04/09/acc26-amgens-repatha-cuts-first-major-cv-event-risk-by-31/ 2026-04-09T14:54:14Z Drug and Device World en ACC26: Amgen’s Repatha cuts first major CV event risk by 31% 2026-04-09T14:54:10Z Blog